🔗 Permalink

Inventor profile of:

Sayda M. Elbashir

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-03-20

Top Assignees for applications by Sayda M. Elbashir

The entities that hold a legal rights for patent applications filed by inventor Elbashir Sayda M.:

ModernaTX, Inc. 26 Cambridge, MA United States
modeRNA Therapeutics 14 Cambridge, MA United States
MODERNA THERAPEUTICS, INC. 13 Cambridge, MA United States

Recent patent applications by Elbashir Sayda M.

Sayda M. Elbashir from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-20

US20250090667A1

Human necessities

DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS

#2 | 2025-03-20

US20250090666A1

Human necessities

DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS

#3 | 2025-02-27

US20250064937A1

Human necessities

DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS

#4 | 2025-02-20

US20250057954A1

Human necessities

DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS

#5 | 2024-08-01

US20240252645A1

Human necessities

DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS

#6 | 2024-04-18

US20240123035A1

Human necessities

MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS

#7 | 2022-09-01

US20220273555A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS

#8 | 2021-12-16

US20210386857A1

Human necessities

Delivery and formulation of engineered nucleic acids

#9 | 2021-09-30

US20210299278A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

#10 | 2021-08-05

US20210236655A1

Human necessities

Engineered Nucleic Acids and Methods of Use Thereof

#11 | 2021-04-22

US20210115101A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

#12 | 2020-05-28

US20200164038A1

Human necessities

MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS

#13 | 2019-08-08

US20190240351A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS

#14 | 2019-02-28

US20190060458A1

Human necessities

Delivery and formulation of engineered nucleic acids

#15 | 2018-11-01

US20180311381A1

Human necessities

Modified Polynucleotides for the production of biologics and proteins associated with human disease

#16 | 2018-06-21

US20180170990A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS

#17 | 2018-05-10

US20180125937A1

Human necessities

MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS

#18 | 2018-04-26

US20180112221A1

Chemistry; metallurgy

Engineered Nucleic Acids and Methods of Use Thereof

#19 | 2018-03-29

US20180086816A1

Chemistry; metallurgy

Long-lived polynucleotide molecules

#20 | 2018-03-29

US20180086807A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

#21 | 2018-01-04

US20180002393A1

Chemistry; metallurgy

Modified polynucleotides for the production of oncology-related proteins and peptides

#22 | 2017-12-28

US20170368200A1

Human necessities

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#23 | 2017-12-07

US20170348436A1

Human necessities

In vivo production of proteins

#24 | 2017-09-14

US20170258915A1

Human necessities

Delivery and formulation of engineered nucleic acids

#25 | 2017-02-02

US20170028085A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS

#26 | 2016-12-29

US20160375134A1

Human necessities

Modified polynucleotides for the production of secreted proteins

#27 | 2016-10-06

US20160289674A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS

#28 | 2016-07-14

US20160199513A1

Human necessities

Modified polynucleotides for the production of proteins associated with human disease

#29 | 2016-07-07

US20160193299A1

Human necessities

MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS

#30 | 2016-06-09

US20160158385A1

Human necessities

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#31 | 2016-06-02

US20160152678A1

Chemistry; metallurgy

Modified polynucleotides for the production of oncology-related proteins and peptides

#32 | 2016-06-02

US20160151516A1

Human necessities

Modified polynucleotides for the production of proteins

#33 | 2016-04-28

US20160114011A1

Human necessities

Modified polynucleotides for the production of nuclear proteins

#34 | 2016-03-17

US20160075733A1

Chemistry; metallurgy

Modified polynucleotides for the production of biologics and proteins associated with human disease

#35 | 2016-01-28

US20160024181A1

Chemistry; metallurgy

LONG-LIVED POLYNUCLEOTIDE MOLECULES

#36 | 2015-12-31

US20150376648A1

Chemistry; metallurgy

In vivo production of proteins

#37 | 2015-12-24

US20150368665A1

Chemistry; metallurgy

Modified polynucleotides for the production of secreted proteins

#38 | 2015-09-03

US20150246139A1

Human necessities

Modified polynucleotides for the production of nuclear proteins

#39 | 2015-04-23

US20150111248A1

Chemistry; metallurgy

In vivo production of proteins

#40 | 2015-03-26

US20150086614A1

Chemistry; metallurgy

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#41 | 2015-03-05

US20150064725A1

Chemistry; metallurgy

Engineered nucleic acids and methods of use thereof

#42 | 2015-03-05

US20150064236A1

Human necessities

Modified polynucleotides for the production of proteins

#43 | 2015-03-05

US20150064235A1

Chemistry; metallurgy

Modified polynucleotides

#44 | 2015-01-15

US20150017211A1

Human necessities

Delivery and formulation of engineered nucleic acids

#45 | 2014-07-17

US20140200262A1

Chemistry; metallurgy

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

#46 | 2014-05-29

US20140147432A1

Chemistry; metallurgy

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

#47 | 2014-01-09

US20140010861A1

Human necessities

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

#48 | 2013-10-10

US20130266640A1

Human necessities

MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS

#49 | 2013-10-03

US20130259924A1

Chemistry; metallurgy

Modified polynucleotides for the production of biologics and proteins associated with human disease

#50 | 2013-10-03

US20130259923A1

Chemistry; metallurgy

Modified polynucleotides for the production of secreted proteins

#51 | 2013-09-26

US20130253043A1

Chemistry; metallurgy

Modified polynucleotides for the production of G-CSF

#52 | 2013-09-19

US20130245107A1

Human necessities

DLIN-MC3-DMA LIPID NANOPARTICLE DELIVERY OF MODIFIED POLYNUCLEOTIDES

#53 | 2013-09-19

US20130245106A1

Human necessities

METHOD OF PRODUCING A PROTEIN OF INTEREST

#54 | 2013-09-19

US20130245105A1

Human necessities

DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides

#55 | 2013-09-19

US20130245104A1

Human necessities

Method for producing a protein of interest in a primate

#56 | 2013-09-19

US20130245103A1

Chemistry; metallurgy

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF FACTOR IX

#57 | 2013-09-19

US20130244282A1

Chemistry; metallurgy

METHOD OF PRODUCING ANTIBODIES

#58 | 2013-09-12

US20130237594A1

Human necessities

Split dose administration

#59 | 2013-09-12

US20130237593A1

Human necessities

MULTI-SITE ADMINISTRATION

#60 | 2013-06-20

US20130156849A1

Human necessities

MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS

#61 | 2012-10-04

US20120251618A1

Human necessities

Engineered nucleic acids encoding a modified erythropoietin and their expression

#62 | 2012-09-20

US20120237975A1

Human necessities

ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

InventorID:

298883 ⎘